Agenus (AGEN) Net Cash Flow Growth (5y) (2015 - 2026)
Agenus (AGEN) Net Cash Flow Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Nanobiotix | 1,785.82 Bn | 1,785.76 Bn | - |
| 2 | Akari Therapeutics | 979.03 Bn | 979.03 Bn | - |
| 3 | BeOne Medicines | 473.13 Bn | 468.34 Bn | 1.35 Bn |
| 4 | Vertex Pharmaceuticals | 123.67 Bn | 116.43 Bn | 2.59 Bn |
| 5 | Regeneron Pharmaceuticals | 71.57 Bn | 62.81 Bn | 3.31 Bn |
| 6 | Belite Bio | 62.00 Bn | 62.00 Bn | - |
| 7 | Argenx Se | 54.61 Bn | 49.42 Bn | 1.41 Bn |
| 8 | Alnylam Pharmaceuticals | 37.99 Bn | 34.98 Bn | 959.66 Mn |
| 9 | Revolution Medicines | 36.09 Bn | 36.09 Bn | - |
| 10 | Agenus | 240.74 Mn | 205.74 Mn | 33.74 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.84% |
| Dec 31, 2025 | 47.63% |
| Sep 30, 2025 | -17.39% |
| Jun 30, 2025 | 7.31% |
| Mar 31, 2025 | -22.17% |
| Dec 31, 2024 | 32.87% |
| Sep 30, 2024 | -11.23% |
| Jun 30, 2024 | 25.38% |
| Mar 31, 2024 | -17.29% |
| Dec 31, 2023 | -44.53% |
| Sep 30, 2023 | -68.52% |
| Jun 30, 2023 | -19.82% |
| Mar 31, 2023 | -11.60% |
| Dec 31, 2022 | -44.33% |
| Sep 30, 2022 | -3.19% |
| Jun 30, 2022 | 9.27% |
| Mar 31, 2022 | -24.95% |
| Dec 31, 2021 | 4.16% |
| Sep 30, 2021 | 29.95% |
| Jun 30, 2021 | -27.94% |